Product Information
MEMANTINE HCL 2 MG/ML SOLUTION is a generic product labeled by Seton Pharmaceuticals, priced at $0.3908 per ML under NDC 13925054012. Its NADAC has been published 116 times since Apr 17, 2024.
FDA first approved this application on Aug 31, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/mL
Manufacturer
Seton PharmaceuticalsNDC
13925054012
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210319FDA Approved
8/31/2020
TE Code
AA
On Market Since
8/31/2020
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 2 MG/ML SOLUTION has been published 116 times since Apr 17, 2024, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3908 per ML |
|---|---|
| All-time high | $0.6425 (May 15, 2024) |
| All-time low | $0.3908 (Jun 17, 2026) |
| 52-week high | $0.4640 |
| 52-week low | $0.3908 |
| Median price | $0.4465 |
| Average price | $0.4783 |
| Largest weekly change | +16.8% (Oct 22, 2025) |
| Weeks tracked | 116 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
-12.5%
1Y
-1.6%
3Y
N/A
5Y
N/A
All
-39.2%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Memantine Hydrochloride Oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Seton Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Memantine Hydrochloride Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 2 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 2 MG/ML SOLUTION, manufactured by Seton Pharmaceuticals, is $0.3908 per ML (NDC 13925054012), effective Jul 1, 2026.
How has the price of MEMANTINE HCL 2 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 2 MG/ML SOLUTION has declined 39.2%. It has been tracked across 116 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 2 MG/ML SOLUTION?
Since Apr 17, 2024, the NADAC for MEMANTINE HCL 2 MG/ML SOLUTION has ranged from a low of $0.3908 (Jun 17, 2026) to a high of $0.6425 (May 15, 2024), with a median of $0.4465 per ML.
Are there cheaper alternatives to MEMANTINE HCL 2 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of MEMANTINE HCL 2 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEMANTINE HCL 2 MG/ML SOLUTION?
MEMANTINE HCL 2 MG/ML SOLUTION (NDC 13925054012) is labeled by Seton Pharmaceuticals, and CMS classifies it as a generic product.